Merck Millipore collaborates with Peking University

Merck Millipore, the Life Science division of Merck, announced today that the division was invited to serve on the faculty of the Center for Pharmaceutical Information and Engineering Research (CPIER) at Peking University in China. The groundbreaking program, established in 2006 with the help of the U.S. Food and Drug Administration, relies on faculty from industry partners to prepare master’s degree candidates in its international pharmaceutical engineering program. Through the program, these future leaders gain a deeper understanding of pharmaceutical research and development, manufacturing and regulatory agencies in China.

“It’s a privilege for Merck Millipore to collaborate with top pharmaceutical companies and regulators in delivering a curriculum to advance industry best practices in China,” said Jean-Paul Mangeolle, head of Merck Millipore’s Process Solutions business. “Our expertise will help ensure that education focuses on the quality and safety of products – made and consumed locally – in the years to come.”

The CPIER’s education program has a faculty of approximately 80 lecturers and 170 master’s degree students who work at manager-level positions in the biopharmaceutical industry. Faculty from Merck Millipore — the only filtration and separation company invited to participate in the master’s course – teach a module on quality and production processes, focusing on sterilizing filtration, aseptic processing and critical filter validation.

In 2011, Merck Millipore opened a state-of-the-art Biopharmaceutical Technical and Training Center in Shanghai, China, reinforcing its commitment to support the production of safe, quality drugs in the region. CPIER will utilize the center for GMP and aseptic process manufacturing training.